• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Molina Healthcare (MOH) Looks Fairly Valued On Its 2027 Earnings Framework

    Simply Wall St·11/12/2026 03:30:07
    Listen to the news

    Molina Healthcare (MOH) drew fresh attention after its CFO used the UBS Global Healthcare Conference to outline a 2027 earnings framework and address key Medicaid and Florida contract questions that matter for valuation.

    Molina Healthcare’s share price has been choppy around the latest conference update, with a 1-day share price return of 1.41% and a 7-day share price return that fell 7.58%. The year-to-date share price return of 17.25% sits alongside a 1-year total shareholder return of 48.37%, pointing to strong momentum over the past year, but still set against a weaker 3-year and 5-year total shareholder return.

    Seize the chance to stack Molina Healthcare’s Medicaid and Medicare story against a curated shortlist of peers with resilient cash flows and balance sheets through our 30 resilient stocks with low risk scores.

    Molina Healthcare’s share price has surged over the past year but slipped after the UBS update. The real puzzle now is whether that 2027 earnings framework still leaves meaningful upside, or if most of the move is already in the rear-view mirror.

    Most Popular Narrative: 3% Undervalued

    Molina Healthcare last closed at $209.25 against a fair value from the analyst consensus Narrative on Simply Wall St of $216.29. This points to a small discount that leans on Medicaid margin recovery, duals growth, and tighter ACA exposure.

    The current valuation implies the share price already reflects a fair outcome in which embedded earnings from Medicaid margin recovery, duals growth, and disciplined capital use are realised without major ACA or rate setting setbacks.

    See why 65 investors see Molina Healthcare as 3% undervalued.

    Result: Fair Value of $216.29 (UNDERVALUED)

    Still, Medicaid funding changes or further ACA Marketplace strain could quickly pressure Molina Healthcare’s margins and weaken the earnings path implied in today’s fair-value narrative.

    Find out about the key risks to this Molina Healthcare narrative.

    Next Steps

    If the mixed tone on Molina Healthcare has you torn, move fast and test the narrative against the underlying numbers yourself. To see what investors view as the main upside potential, take a closer look at the 3 key rewards.

    Looking for more Molina Healthcare investment ideas?

    If Molina Healthcare has sharpened your focus on quality, do not stop here. Broaden your watchlist now or risk missing opportunities sitting in plain sight.